Photoproximity labeling of c-Myc reveals SLK as a cancer-specific co-regulator
A photoproximity-labeling approach maps cancer-specific partners of the c-Myc oncoprotein, revealing that the kinase SLK binds and stabilizes c-Myc, drives tumor growth and offers a new strategy to target this long-‘undr
Cancer research has long been hindered by the elusive nature of the c-Myc oncoprotein, a protein known for its role in promoting cell proliferation and tumorigenesis. Recent studies have employed photoproximity-labeling approaches to elucidate the interactions between c-Myc and other proteins within the cancer cell. These investigations have yielded significant insights into the molecular mechanisms underlying cancer progression. One such study has identified SLK, a kinase previously uncharacterized in this context, as a key partner of c-Myc. The findings reveal that SLK binds to c-Myc, stabilizing it and facilitating its oncogenic activity. This interaction not only drives tumor growth but also provides a novel target for therapeutic intervention. By elucidating the molecular mechanisms underlying cancer progression, researchers can develop more effective strategies for treating this devastating disease. Further research is needed to fully understand the implications of these findings and to explore potential therapeutic applications.